Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Aseptic Technique SOP for AMD – V 2.0

Posted on By

Analytical Method Development: Aseptic Technique SOP for AMD – V 2.0

Standard Operating Procedure for Aseptic Technique in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/133/2025
Supersedes SOP/AMD/133/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines aseptic techniques to be followed during sample handling, testing, and media preparation within the Analytical Method Development (AMD) laboratory, to prevent contamination and maintain data integrity during microbiological analysis.

2. Scope

This SOP

applies to all AMD personnel involved in microbiological testing procedures such as sterility testing, microbial limit testing, environmental monitoring, and preservative efficacy studies conducted under aseptic conditions.

3. Responsibilities

  • Microbiologist: Implements aseptic technique in all sample handling and testing steps, ensures regular sanitization of the LAF, and maintains logs.
  • Analytical Scientist: Ensures compliance during transfers of materials and samples into aseptic areas.
  • QA Officer: Conducts periodic audits to verify adherence to aseptic practices and evaluates training records.
  • Head – AMD: Approves aseptic protocols and ensures training, qualification, and documentation.
See also  Analytical Method Development: Validation-Readiness Evaluation of Developed Methods - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring aseptic technique implementation, periodic retraining, and maintenance of a contamination-free testing environment.

5. Procedure

5.1 Personal Hygiene and Gowning

  1. Personnel must be free from contagious illness or skin infections.
  2. Perform hand washing with antimicrobial soap followed by drying with sterile towels.
  3. Wear sterile gown, gloves, face mask, cap, and shoe covers in the designated gowning area.
  4. Disinfect gloves using 70% IPA before entering the LAF.

5.2 Area Preparation

  1. Switch on the LAF 30 minutes prior to use and verify airflow with an anemometer if required.
  2. Wipe all interior surfaces with sterile 70% IPA or appropriate disinfectant.
  3. Place UV lamp ‘ON’ for 15–30 minutes if applicable, and turn off before work begins.
  4. Ensure that all required materials (media, pipettes, tubes) are sterilized and placed aseptically in the LAF.
  5. Record cleaning activities in Annexure-1: Aseptic Area Preparation Log.

5.3 Handling of Samples and Materials

  1. Minimize movement within and around the LAF during operation to avoid air turbulence.
  2. Disinfect external surfaces of containers and materials with 70% IPA before placing inside LAF.
  3. Work at least 6 inches inside the LAF to avoid external air disturbance.
  4. Use sterile forceps and avoid touching critical parts of sterile equipment (e.g., pipette tips, tube openings).
See also  Analytical Method Development: Selection of Mobile Phase for Chromatographic Techniques - V 2.0

5.4 Aseptic Techniques During Testing

  1. Do not talk, cough, or sneeze inside the LAF. Avoid rapid hand movements.
  2. Flame sterilize tools like inoculating loops using spirit lamps or Bunsen burners.
  3. Cap and uncap sample containers one at a time. Do not leave containers open unnecessarily.
  4. Perform all microbial transfers using sterile pipettes or micropipettors with barrier tips.
  5. Document each aseptic test activity in Annexure-2: Test Execution Log.

5.5 Post-Testing Activities

  1. Dispose of all used material in designated autoclave or biohazard bags.
  2. Disinfect LAF interior with 70% IPA and allow it to run for 15 minutes post-use.
  3. Update LAF usage log with date, time, analyst name, and activity performed.

5.6 Qualification and Training

  1. Personnel must undergo initial aseptic technique training and annual retraining.
  2. Evaluate practical skills using media fill simulation or growth media handling challenge tests.
  3. Maintain training records in Annexure-3: Personnel Qualification Log.

See also  Analytical Method Development: SOP for Specificity Testing During Validation - V 2.0

6. Abbreviations

  • LAF: Laminar Airflow
  • IPA: Isopropyl Alcohol
  • GMP: Good Manufacturing Practice
  • GLP: Good Laboratory Practice
  • SOP: Standard Operating Procedure

7. Documents

  1. Aseptic Area Preparation Log – Annexure-1
  2. Test Execution Log – Annexure-2
  3. Personnel Qualification Log – Annexure-3

8. References

  • USP <797> – Pharmaceutical Compounding—Sterile Preparations
  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
  • WHO Guidelines on Good Manufacturing Practices

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Aseptic Area Preparation Log

Date LAF ID Disinfectant Used Sanitized By Remarks
18/05/2025 LAF-002 IPA 70% Rajesh Kumar Cleaned & Ready

Annexure-2: Test Execution Log

Date Sample ID Test Performed Analyst Remarks
19/05/2025 MLT/25/101 Microbial Limit Test Sunita Reddy Completed

Annexure-3: Personnel Qualification Log

Name Date Trained Trainer Evaluation Method Status
Ajay Verma 10/04/2025 QA Trainer Media Fill Qualified

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded aseptic gowning and LAF validation protocol Annual GMP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Endotoxin Testing of Intravenous Injections – V 2.0
Next Post: Aerosol: SOP for Label Verification During Aerosol Packing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version